Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aerovate Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12.5K | $205K | $16.37 | Jun 5, 2024 | Direct |
Surrozen, Inc./DE | Former Director | Common Stock | 30K | $11.4K | $0.38 | Aug 11, 2021 | Direct |
Oyster Point Pharma, Inc. | Director | Common Stock | 0 | $11.20 | Jan 3, 2023 | Direct | |
Oyster Point Pharma, Inc. | Director | Stock Option (Right to Buy) | 0 | Jan 3, 2023 | Direct | ||
Surrozen, Inc./DE | Former Director | Class B Ordinary Shares | 0 | Aug 11, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVTE | Aerovate Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jan 2, 2024 | 1 | $39K | 4 | Jan 4, 2024 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jan 19, 2023 | 2 | $39K | 4 | Jan 23, 2023 | Director |
AVTE | Aerovate Therapeutics, Inc. | Jan 19, 2023 | 0 | $0 | 3 | Jan 23, 2023 | Director |
OYST | Oyster Point Pharma, Inc. | Jan 3, 2023 | 4 | $0 | 4 | Jan 4, 2023 | Director |
OYST | Oyster Point Pharma, Inc. | Jun 6, 2022 | 2 | $0 | 4 | Jun 8, 2022 | Director |
SRZN | Surrozen, Inc./DE | Aug 11, 2021 | 2 | $0 | 4 | Aug 13, 2021 | Former Director |
OYST | Oyster Point Pharma, Inc. | Jul 30, 2021 | 4 | $0 | 4 | Aug 3, 2021 | Director |
OYST | Oyster Point Pharma, Inc. | Jul 30, 2021 | 0 | $0 | 3 | Aug 3, 2021 | Director |